Synergies in M&A: Types, Examples, and How They Are Actually Valued (2026)
M&A advisory at Peony. Former investment banker at Moelis & Company, where I worked on cross-border M&A across healthcare, industrials, and consumer. I write about how deals actually get diligenced and closed.
Synergies in M&A: Types, Examples, and How They Are Actually Valued (2026)
Last updated: August 2026
Quick answer. A synergy is the value created when two companies are worth more combined than the sum of their standalone parts. Synergies come in three types, sorted into a simple 2x2 of cost versus revenue (plus a third, financial): cost synergies strip out duplicated expense, revenue synergies add sales neither party could earn alone, and financial synergies improve the balance sheet. They matter because they justify the premium a buyer pays. When Union Pacific agreed to acquire Norfolk Southern in July 2025, it told investors the deal would produce $2.75 billion in annual synergies within three years, split into $1.75 billion of revenue and $1 billion of cost (Union Pacific).
I'm Chris Chen. Before joining Peony, I worked in M&A at Moelis & Company across cross-border, healthcare, industrials, and consumer transactions. Synergy numbers are what justify the premiums buyers pay over market price, and most deal models live or die on them: get the synergy case wrong and you have overpaid, no matter how good the strategic story sounds. The word gets used loosely everywhere, in press releases, banker decks, and board memos, to mean anything vaguely positive about a combination. This is the precise map: what a synergy actually is, the three types, real 2026 examples with the dollar figures companies published, and the math buyers use to put a defensible number on it.
This post owns the taxonomy and the valuation math. For the deal stories themselves see mergers and acquisitions examples; for how you actually capture the value after signing see the acquisition integration guide.
What are synergies in M&A?
A synergy is the value created when two companies combined are worth more than the sum of their standalone values. The textbook shorthand is one plus one equals three. But a real synergy is never a vague "we'll be stronger together" claim; it is a specific, quantifiable change to future cash flow that exists only because the deal happened, either a cost the combined company stops paying or revenue neither company could earn alone.
Synergies are the economic justification for a control premium. Acquirers almost always pay more than the target's pre-deal trading price, often a 20% to 30% premium, and that premium has to come from somewhere. The bet is that synergies exceed the premium. If they do, the acquirer's shareholders come out ahead; if they do not, the deal transfers value from the buyer to the seller. That single tension, synergy value versus premium paid, is the whole game, and it is why every credible synergy claim needs a number, a timeline, and a source.
A useful distinction up front: synergy is not the same as scale or "strategic fit." Buying a competitor makes you bigger, but bigger only creates value if it produces a specific cost or revenue effect you can name and measure. If you cannot write it as a line in a model with a dollar figure attached, it is a narrative, not a synergy.
What are the types of synergies?
There are three types of synergy, and disciplined buyers treat them very differently because they carry very different confidence levels.
Cost synergies remove expense from the combined business. The three sub-categories are procurement (buying at higher combined volume for better unit prices), overhead (eliminating duplicated corporate, finance, HR, IT, and back-office functions), and footprint (closing redundant plants, offices, and distribution centers). Cost synergies are the most forecastable because they come off a known, documented expense base.
Revenue synergies add sales the companies could not generate alone. The mechanisms are cross-selling (selling each company's products to the other's customers), pricing power (a stronger bundle or reduced competition), and distribution (reaching new channels or geographies). Revenue synergies are the least reliable because they depend on customer behavior after close.
Financial synergies improve the capital structure rather than operations: using a target's tax attributes, achieving a lower cost of capital as a larger and more diversified borrower, and supporting more debt capacity on steadier combined cash flow. These are real but usually the smallest bucket, and boards scrutinize any deal justified mainly on tax.
| Type | Sub-categories | Typical timing | Confidence | Who controls it |
|---|---|---|---|---|
| Cost | Procurement, overhead, footprint | 12–18 months | Highest | Mostly the acquirer |
| Revenue | Cross-sell, pricing, distribution | 24–36 months | Lowest | Customers and sales teams |
| Financial | Tax, cost of capital, debt capacity | At or soon after close | Moderate | Capital markets and tax rules |
The single most useful habit when reading any announced synergy target is to ask for the split. A target weighted toward cost is more credible than the same headline number weighted toward revenue. Realization rates differ sharply by category and by deal type, and the types of mergers and acquisitions guide breaks down how much of each category actually lands by horizontal, vertical, and conglomerate structure.
What are real examples of announced synergies?
Announced synergy targets are verifiable because acquirers publish them, and the interesting part is comparing the promise to what happened. Here are four sourced cases.
Union Pacific and Norfolk Southern (2025). In announcing the roughly $85 billion combination on July 29, 2025, the railroads projected $2.75 billion in annualized synergies within three years, split in their merger materials into $1.75 billion of revenue growth and $1 billion of cost savings, alongside a 25% premium to Norfolk Southern shareholders (Union Pacific). It is a rare deal that leads with revenue synergies exceeding cost, a reflection of the network effects of a transcontinental railroad, and precisely the kind of split that deserves scrutiny.
ExxonMobil and Pioneer Natural Resources. When Exxon announced the ~$60 billion acquisition on October 11, 2023, it guided to synergies approaching $2 billion per year. By its December 9, 2025 update, Exxon had raised the figure to $4 billion annually, double the initial estimate (ExxonMobil). This is the upside case: a mostly operational, cost-and-efficiency synergy set in a business with a documented cost base, revised up as integration delivered.
Charter and Cox Communications. Charter's May 16, 2025 agreement to combine with Cox targeted roughly $500 million in annualized cost synergies within three years, from procurement and overhead (Charter). A textbook horizontal cost case, and notably conservative: management framed it around expenses it could control rather than speculative cross-sell.
Kraft and Heinz (2015). The merger targeted $1.5 billion in annual cost savings by the end of 2017. The savings were real, but the aggressive cost-cutting is widely seen as having starved the brands, and in February 2019 Kraft Heinz took a $15.4 billion write-down ($7.1 billion goodwill plus $8.3 billion of intangible assets) on the Kraft and Oscar Mayer brands (SEC 8-K, Feb 21 2019). It is the cautionary case: hitting the cost-synergy target is not the same as creating durable value.
I am not going to re-narrate these deals; the mergers and acquisitions examples post covers the stories. The point here is the pattern: cost-led targets tend to hold or beat plan, revenue-led targets carry more risk, and a synergy number hit on paper can still coincide with value destruction.
How are synergies valued in a deal model?
Synergies are valued as the net present value of after-tax synergy cash flows, phased over the years they realize, minus the one-time costs to achieve them. That one sentence is the entire method; everything else is filling in the inputs. Here is the sequence a corp-dev or banking team runs.
- Estimate the annual run-rate for each synergy line separately, cost and revenue and financial, not one blended number. Ground each line in a driver: procurement savings as a percentage of addressable spend, overhead as specific headcount and facilities, cross-sell as an attach rate on a defined customer base.
- Tax-affect each line. Synergies flow through the P&L, so a pre-tax saving is worth less after tax. Apply the combined entity's marginal rate.
- Phase them in. Cost synergies typically ramp over 12 to 18 months; revenue synergies over 24 to 36. A synergy that arrives in Year 3 is worth far less than one banked in Year 1, and phasing is where optimistic models quietly inflate value by pulling everything forward.
- Subtract costs-to-achieve. Integration is not free: severance, systems migration, advisory fees, and rebranding. A common rule of thumb is that one-time costs to achieve run roughly one year of the annual run-rate, sometimes more. These are real cash outflows and belong in the model, netted against the gross synergies.
- Discount the net stream at the acquirer's weighted average cost of capital to get a present value.
The output is a single synergy NPV. Now compare it to the premium. If a buyer pays a 25% premium and the risk-adjusted synergy NPV is worth less than that premium, the deal has handed the value to the seller and diluted the acquirer's shareholders. This is why the disciplined move is to haircut revenue synergies hard, or refuse to pay for them at all, and underwrite the premium primarily against cost synergies you can document. Paying today for revenue synergies that may never arrive is the single most common way acquirers destroy value. Sensitivity analysis matters here: a model that only works at 100% synergy realization and zero slippage is a model that will not survive contact with integration.
Why do synergies fail to materialize?
Synergies fail for three recurring reasons, and they compound.
Revenue synergies are overestimated at signing. They are the easiest to promise and the hardest to test, so they attract the most optimism. McKinsey Quarterly research (2004) found that roughly 70% of mergers failed to achieve their expected revenue synergies, and cost synergies were estimated far more accurately than revenue ones. When a deal leads with a big revenue-synergy line, that is where the skepticism belongs.
Integration and culture stall execution. A synergy is a promise about future cash flow, and cash flow is captured by people running systems migrations, renegotiating contracts, and holding on to key staff and customers. When integration drags, the synergy clock runs out: the value was theoretically available but the organization could not reach it in time. Culture is the usual culprit, and the acquisition integration guide covers why.
Dis-synergies appear that the model ignored. These are negative effects the combination creates. Overlapping customers consolidate their spend to a single vendor or leave for a competitor; a combined entity's pricing invites a competitive response; distracted managers take their eye off the base business; talent walks. Customer overlap is the sharpest one in horizontal deals, exactly the case where the acquirer expected the biggest revenue synergies.
The honest through-line: the failures are usually not surprises about integration difficulty. They are a symptom of the original number. When the announced synergy target was really the bid premium rebranded as an operating plan, no integration team can execute it, because it was never an operating plan in the first place.
What is the difference between synergies and integration?
The synergy is the value claim; integration is the execution that delivers it. Keeping the two separate is one of the most useful disciplines in M&A, because deals are priced on synergies but won or lost on integration.
A synergy is a number in the valuation model: "the combined company will save $200 million a year in procurement." Integration is the operational program that turns that number into realized cash flow: renegotiating the actual vendor contracts, consolidating the two purchasing teams, migrating to one ERP, and tracking the savings to the P&L. One is a forecast; the other is a project plan with owners, milestones, and a budget.
Why the distinction is load-bearing: a synergy case with no credible integration plan is just a spreadsheet, and a board should discount it accordingly. Equally, world-class integration cannot save a deal whose synergy assumptions were fiction, because you cannot execute your way to value that was never there. The best acquirers pressure-test both at once, asking not only "is this synergy real?" but "who owns delivering it, by when, and what does it cost?" For the execution side, the acquisition integration guide is the companion to this post; if you are still deciding whether your deal is even a merger or an acquisition in the first place, merger vs acquisition draws that line.
How do buyers validate synergy assumptions in diligence?
Buyers validate synergies by tracing every line in the synergy model back to a source document in the target's data room. A synergy claim you cannot tie to evidence is one you should haircut to zero. Diligence is where the announced number meets the paper trail.
The mapping is specific by category. Cost synergies get tested against procurement contracts and vendor spend files (to confirm the addressable base and the pricing you can renegotiate), org charts and headcount detail (for overhead), and lease and facility schedules (for footprint). Revenue synergies get tested against customer lists, a customer-overlap analysis, and contract assignability (a cross-sell plan is worthless if the target's contracts cannot transfer or its customers already buy from you). Systems and IT synergies get tested against an application inventory and integration cost estimates. This is also where dis-synergies surface: the overlap analysis that reveals two big customers are shared, so the revenue synergy is really a retention risk.
At Peony, a data room company I help run, this is the workflow we see across a large share of our 6,800+ customers: a buyer's deal team works a structured Q&A thread tied to specific documents, and the Peony data room surfaces page-level analytics showing which files buyers actually opened and studied. That last part is quietly powerful for validating synergies, because a revenue-synergy assumption that nobody on the deal team ever opened the supporting contract for is an assumption built on air. For the full workflow, our M&A due diligence process guide walks the whole sequence; the synergy-validation piece is one workstream inside it.
The practical mechanics matter to more than just enterprise buyers. Analytics and link expiry are available on every Peony tier including the free plan, one-click revoke is on Business and up, and viewers are always free, so a deal team can invite every advisor and diligence lead without per-seat cost. The Data Room plan at $52 per admin per month billed annually ($75 monthly) adds dynamic watermarking and Advanced NDA for the sensitive files (customer lists, supplier terms) that synergy diligence actually turns on; the Business plan at $30 per admin per month ($44 monthly) covers a lighter process with Simple NDA gating. With 6,800+ customers running deals this way, the pattern is consistent: the synergy lines that survive diligence are the ones with a document behind them.
Frequently asked questions
The FAQ schema for this article is embedded in the page metadata above and covers: what synergies are, the three types, revenue versus cost versus financial synergies, how synergies are valued, who captures the value, why synergies fail, the synergy-versus-integration distinction, and how deal teams validate synergy assumptions in diligence.
Related resources
- Mergers and acquisitions examples — the deal stories behind the synergy numbers
- Types of mergers and acquisitions — how synergy realization differs by deal structure
- Merger vs acquisition — the legal and structural distinction
- Acquisition integration guide — how synergies get captured after close
- M&A due diligence process guide — the full diligence workstream
- Peony for M&A — the data room deal teams use to validate synergy assumptions
You might also like
Aug 26, 2026
Vertical vs. Horizontal Integration: Differences, Forward and Backward Types, and Examples (2026)
Aug 25, 2026
How to Sell a Dental Practice in 2026: Valuation, Process, and Exit Paths
Aug 25, 2026
Should You Sell Your Dental Practice to a DSO? How to Evaluate the Offer (2026)

